Treatment with metformin and a dipeptidyl peptidase-4 inhibitor elevates apelin levels in patients with type 2 diabetes mellitus

BACKGROUND: The objective of this study was to assess the effects of metformin monotherapy or combined treatment with a dipeptidyl peptidase-4 inhibitor (vildagliptin) on apelin levels in patients with type 2 diabetes mellitus. METHODS: Twenty-five patients with poor glycemic control (glycosylated h...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yujuan, Zhang, Yu, Li, Xuesong, Zheng, Hui, Song, Yuping, Zhang, Ning, Shen, Chunfang, Fan, Xiaofang, Ren, Fengdong, Shen, Jiayi, Ren, Guoguang, Yang, Jialin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544807/
https://www.ncbi.nlm.nih.gov/pubmed/26316706
http://dx.doi.org/10.2147/DDDT.S85740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544807/
https://www.ncbi.nlm.nih.gov/pubmed/26316706
http://dx.doi.org/10.2147/DDDT.S85740

Ejemplares similares